People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Window Therapeutics, Inc. | — | Biotechnology | Series A | $7.5M | $57.3M | 2023 |
| Ribonaut Therapeutics, Inc. | — | Biotechnology | Series A | $6.9M | $79.7M | 2022 |
| Duo Oncology Inc. | — | Pharmaceuticals | Series A | $5.8M | $1.4M | 2025 |
LUSONG LUO at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside LUSONG LUO on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kenneth Anderson | 1 | 5 |
| STANLEY MARKS | 1 | 4 |
| James Lu | 1 | 3 |
| Robert Ashley | 1 | 3 |
| Song Li | 1 | 3 |
| Zachary Collins | 1 | 3 |
| Steven Tregay | 1 | 2 |
| JING-ZHOU HOU | 1 | 2 |
| STEPHEN THORNE | 1 | 2 |
| VICTORIA MANAX | 1 | 2 |
| Chih-Kao Hu | 1 | 2 |
| Matthew Disney | 1 | 2 |
| JOE GATTO | 1 | 1 |
| JINGJING SUN | 1 | 1 |
| Jeremiah Johnson | 1 | 1 |
| Jessica Childs-Disney | 1 | 1 |
| SAM ROTHSTEIN | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.